CUA Educational Content

Practice Changing Publications (PCP): Update in Kidney Cancer

EDITORIAL COMMITTEE: Anil Kapoor and Luke Lavallée

By the end of this presentation, participants will be able to:

  • Understand the latest key findings in localized and metastatic kidney cancer
  • Discuss first line options for the systemic treatment of metastatic kidney cancer
  • Discuss how to counsel patients with small renal masses
  • Discuss the role for renal hypothermia in partial nephrectomy
  • Discuss the role for adjuvant therapy in high risk resected kidney cancer
  • Discuss the contemporary role for cytoreductive nephrectomy
  • Discuss the role for Belzutifan in VHL patients

Start Quiz for Credits

ACCREDITATION

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Urological Association. You may claim a maximum of 1 hour of credit.

 

This program has received financial support from Bristol Myers Squibb and Pfizer in the form of an educational grant.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy